Global Radioligand Therapy Market 2025 by Company, Regions, Type and Application, Forecast to 2031

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Radioligand Therapy by Type
  • 1.3.1 Overview: Global Radioligand Therapy Market Size by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 Global Radioligand Therapy Consumption Value Market Share by Type in 2024
  • 1.3.3 Actinium 225 (Ac-225)
  • 1.3.4 Lutetium 177 (Lu-177)
  • 1.3.5 Gallium 68 (Ga-68)
  • 1.3.6 Fluorine 18 (F-18)
  • 1.3.7 Other Radionuclides
• 1.4 Global Radioligand Therapy Market by Application
  • 1.4.1 Overview: Global Radioligand Therapy Market Size by Application: 2020 Versus 2024 Versus 2031
  • 1.4.2 Neuroendocrine Neoplasms
  • 1.4.3 Prostate Cancer
• 1.5 Global Radioligand Therapy Market Size & Forecast
• 1.6 Global Radioligand Therapy Market Size and Forecast by Region
  • 1.6.1 Global Radioligand Therapy Market Size by Region: 2020 VS 2024 VS 2031
  • 1.6.2 Global Radioligand Therapy Market Size by Region, (2020-2031)
  • 1.6.3 North America Radioligand Therapy Market Size and Prospect (2020-2031)
  • 1.6.4 Europe Radioligand Therapy Market Size and Prospect (2020-2031)
  • 1.6.5 Asia-Pacific Radioligand Therapy Market Size and Prospect (2020-2031)
  • 1.6.6 South America Radioligand Therapy Market Size and Prospect (2020-2031)
  • 1.6.7 Middle East & Africa Radioligand Therapy Market Size and Prospect (2020-2031)

2 Company Profiles

• 2.1 Novartis
  • 2.1.1 Novartis Details
  • 2.1.2 Novartis Major Business
  • 2.1.3 Novartis Radioligand Therapy Product and Solutions
  • 2.1.4 Novartis Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 Novartis Recent Developments and Future Plans
• 2.2 Advanced Accelerator Applications
  • 2.2.1 Advanced Accelerator Applications Details
  • 2.2.2 Advanced Accelerator Applications Major Business
  • 2.2.3 Advanced Accelerator Applications Radioligand Therapy Product and Solutions
  • 2.2.4 Advanced Accelerator Applications Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 Advanced Accelerator Applications Recent Developments and Future Plans
• 2.3 Mercy Radiology
  • 2.3.1 Mercy Radiology Details
  • 2.3.2 Mercy Radiology Major Business
  • 2.3.3 Mercy Radiology Radioligand Therapy Product and Solutions
  • 2.3.4 Mercy Radiology Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  • 2.3.5 Mercy Radiology Recent Developments and Future Plans
• 2.4 POINT Biopharma Global Inc
  • 2.4.1 POINT Biopharma Global Inc Details
  • 2.4.2 POINT Biopharma Global Inc Major Business
  • 2.4.3 POINT Biopharma Global Inc Radioligand Therapy Product and Solutions
  • 2.4.4 POINT Biopharma Global Inc Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  • 2.4.5 POINT Biopharma Global Inc Recent Developments and Future Plans
• 2.5 Fusion Pharma
  • 2.5.1 Fusion Pharma Details
  • 2.5.2 Fusion Pharma Major Business
  • 2.5.3 Fusion Pharma Radioligand Therapy Product and Solutions
  • 2.5.4 Fusion Pharma Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  • 2.5.5 Fusion Pharma Recent Developments and Future Plans
• 2.6 Telix Pharmaceuticals Ltd
  • 2.6.1 Telix Pharmaceuticals Ltd Details
  • 2.6.2 Telix Pharmaceuticals Ltd Major Business
  • 2.6.3 Telix Pharmaceuticals Ltd Radioligand Therapy Product and Solutions
  • 2.6.4 Telix Pharmaceuticals Ltd Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  • 2.6.5 Telix Pharmaceuticals Ltd Recent Developments and Future Plans
• 2.7 Lantheus Holdings, Inc
  • 2.7.1 Lantheus Holdings, Inc Details
  • 2.7.2 Lantheus Holdings, Inc Major Business
  • 2.7.3 Lantheus Holdings, Inc Radioligand Therapy Product and Solutions
  • 2.7.4 Lantheus Holdings, Inc Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  • 2.7.5 Lantheus Holdings, Inc Recent Developments and Future Plans
• 2.8 Bayer AG
  • 2.8.1 Bayer AG Details
  • 2.8.2 Bayer AG Major Business
  • 2.8.3 Bayer AG Radioligand Therapy Product and Solutions
  • 2.8.4 Bayer AG Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  • 2.8.5 Bayer AG Recent Developments and Future Plans
• 2.9 Curium Pharma
  • 2.9.1 Curium Pharma Details
  • 2.9.2 Curium Pharma Major Business
  • 2.9.3 Curium Pharma Radioligand Therapy Product and Solutions
  • 2.9.4 Curium Pharma Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  • 2.9.5 Curium Pharma Recent Developments and Future Plans
• 2.10 Precirix
  • 2.10.1 Precirix Details
  • 2.10.2 Precirix Major Business
  • 2.10.3 Precirix Radioligand Therapy Product and Solutions
  • 2.10.4 Precirix Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  • 2.10.5 Precirix Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Radioligand Therapy Revenue and Share by Players (2020-2025)
• 3.2 Market Share Analysis (2024)
  • 3.2.1 Market Share of Radioligand Therapy by Company Revenue
  • 3.2.2 Top 3 Radioligand Therapy Players Market Share in 2024
  • 3.2.3 Top 6 Radioligand Therapy Players Market Share in 2024
• 3.3 Radioligand Therapy Market: Overall Company Footprint Analysis
  • 3.3.1 Radioligand Therapy Market: Region Footprint
  • 3.3.2 Radioligand Therapy Market: Company Product Type Footprint
  • 3.3.3 Radioligand Therapy Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Radioligand Therapy Consumption Value and Market Share by Type (2020-2025)
• 4.2 Global Radioligand Therapy Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

• 5.1 Global Radioligand Therapy Consumption Value Market Share by Application (2020-2025)
• 5.2 Global Radioligand Therapy Market Forecast by Application (2026-2031)

6 North America

• 6.1 North America Radioligand Therapy Consumption Value by Type (2020-2031)
• 6.2 North America Radioligand Therapy Market Size by Application (2020-2031)
• 6.3 North America Radioligand Therapy Market Size by Country
  • 6.3.1 North America Radioligand Therapy Consumption Value by Country (2020-2031)
  • 6.3.2 United States Radioligand Therapy Market Size and Forecast (2020-2031)
  • 6.3.3 Canada Radioligand Therapy Market Size and Forecast (2020-2031)
  • 6.3.4 Mexico Radioligand Therapy Market Size and Forecast (2020-2031)

7 Europe

• 7.1 Europe Radioligand Therapy Consumption Value by Type (2020-2031)
• 7.2 Europe Radioligand Therapy Consumption Value by Application (2020-2031)
• 7.3 Europe Radioligand Therapy Market Size by Country
  • 7.3.1 Europe Radioligand Therapy Consumption Value by Country (2020-2031)
  • 7.3.2 Germany Radioligand Therapy Market Size and Forecast (2020-2031)
  • 7.3.3 France Radioligand Therapy Market Size and Forecast (2020-2031)
  • 7.3.4 United Kingdom Radioligand Therapy Market Size and Forecast (2020-2031)
  • 7.3.5 Russia Radioligand Therapy Market Size and Forecast (2020-2031)
  • 7.3.6 Italy Radioligand Therapy Market Size and Forecast (2020-2031)

8 Asia-Pacific

• 8.1 Asia-Pacific Radioligand Therapy Consumption Value by Type (2020-2031)
• 8.2 Asia-Pacific Radioligand Therapy Consumption Value by Application (2020-2031)
• 8.3 Asia-Pacific Radioligand Therapy Market Size by Region
  • 8.3.1 Asia-Pacific Radioligand Therapy Consumption Value by Region (2020-2031)
  • 8.3.2 China Radioligand Therapy Market Size and Forecast (2020-2031)
  • 8.3.3 Japan Radioligand Therapy Market Size and Forecast (2020-2031)
  • 8.3.4 South Korea Radioligand Therapy Market Size and Forecast (2020-2031)
  • 8.3.5 India Radioligand Therapy Market Size and Forecast (2020-2031)
  • 8.3.6 Southeast Asia Radioligand Therapy Market Size and Forecast (2020-2031)
  • 8.3.7 Australia Radioligand Therapy Market Size and Forecast (2020-2031)

9 South America

• 9.1 South America Radioligand Therapy Consumption Value by Type (2020-2031)
• 9.2 South America Radioligand Therapy Consumption Value by Application (2020-2031)
• 9.3 South America Radioligand Therapy Market Size by Country
  • 9.3.1 South America Radioligand Therapy Consumption Value by Country (2020-2031)
  • 9.3.2 Brazil Radioligand Therapy Market Size and Forecast (2020-2031)
  • 9.3.3 Argentina Radioligand Therapy Market Size and Forecast (2020-2031)

10 Middle East & Africa

• 10.1 Middle East & Africa Radioligand Therapy Consumption Value by Type (2020-2031)
• 10.2 Middle East & Africa Radioligand Therapy Consumption Value by Application (2020-2031)
• 10.3 Middle East & Africa Radioligand Therapy Market Size by Country
  • 10.3.1 Middle East & Africa Radioligand Therapy Consumption Value by Country (2020-2031)
  • 10.3.2 Turkey Radioligand Therapy Market Size and Forecast (2020-2031)
  • 10.3.3 Saudi Arabia Radioligand Therapy Market Size and Forecast (2020-2031)
  • 10.3.4 UAE Radioligand Therapy Market Size and Forecast (2020-2031)

11 Market Dynamics

• 11.1 Radioligand Therapy Market Drivers
• 11.2 Radioligand Therapy Market Restraints
• 11.3 Radioligand Therapy Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Radioligand Therapy Industry Chain
• 12.2 Radioligand Therapy Upstream Analysis
• 12.3 Radioligand Therapy Midstream Analysis
• 12.4 Radioligand Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source